ScholarX: Browsing ScholarWorks

Browsing by Lee, CK[Lee, Choong-kun]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 10 of 10

SCIESCOPUS

A multi-institutional phase Ib/II trial of first-line triplet regimen (Pembrolizumab, Trastuzumab, Chemotherapy) for HER2-positive advanced gastric and gastroesophageal junction cancer (PANTHERA Trial): Molecular profiling and clinical update

Rha, SY[Rha, Sun Young]; Lee, CK[Lee, Choong-kun]; Kim, HS[Kim, Hyo Song]; Kang, B[Kang, Beodeul]; Jung, M[Jung, Minkyu]; Kwon, WS[Kwon, Woo Sun]; Bae, WK[Bae, Woo Kyun]; Koo, DH[Koo, Dong-Hoe]; Shin, SJ[Shin, Su-Jin]; Jeung, HC[Jeung, Hei-Cheul], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.3PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer open access

Lee, CK[Lee, Choong-kun]; Rha, SY[Rha, Sun Young]; Kim, HS[Kim, Hyo Song]; Jung, M[Jung, Minkyu]; Kang, B[Kang, Beodeul]; Che, J[Che, Jingmin]; Kwon, WS[Kwon, Woo Sun]; Park, S[Park, Sejung]; Bae, WK[Bae, Woo Kyun]; Koo, DH[Koo, Dong-Hoe], et al.

ArticleIssue Date2022CitationNATURE COMMUNICATIONS, v.13, no.1PublisherNATURE PORTFOLIO

SCIESCOPUS

Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers

Balogun, F[Balogun, Fiyinfolu]; Altoe, M[Altoe, Mirella]; O'Connor, C[O'Connor, Catherine]; Chowdhury, N[Chowdhury, Nobel]; Cercek, A[Cercek, Andrea]; Lee, CK[Lee, Choong-kun]; Foote, MB[Foote, Michael Bonner]; Kim, D[Kim, Daehee]; Maron, SB[Maron, Steven Brad]; Kim, DW[Kim, Dae Won], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: Multicenter study of the Korean Cancer Study Group (KCSG).

Chon, H[Chon, Hongjae]; Park, HS[Park, Hyung Soon]; Kang, B[Kang, Beodeul]; Im, HS[Im, Hyeon-Su]; Lee, CK[Lee, Choong-kun]; Kim, I[Kim, Ilhwan]; Kang, MJ[Kang, Myoung Joo]; Hwang, JE[Hwang, Jun-Eul]; Kyun, W[Kyun, Woo]; Cheon, J[Cheon, Jaekyung], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY

SCIESCOPUS

Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer (HER-RAM study).

Rha, SY[Rha, Sun Young]; Kim, CG[Kim, Chang Gon]; Jung, M[Jung, Minkyu]; Kim, HS[Kim, Hyo Song]; Lee, CK[Lee, Choong-kun]; Jeung, HC[Jeung, Hei-Cheul]; Koo, DH[Koo, Dong-Hoe]; Bae, WK[Bae, Woo Kyun]; Zang, DY[Zang, Dae Young]; Kim, H[Kim, Hyunki], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysis

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.4PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Open label, single-arm, multi-center phase Ib/II study to evaluate the safety and efficacy of nivolumab in combination with paclitaxel in Epstein-Barr virus (EBV)-related, or microsatellite instability-high (MSI-H), or programmed cell death ligand 1 (PD-L1) positive advanced gastric cancer (AGC).

Young, RS[Young, Rha Sun]; Lee, JB[Lee, Jii Bum]; Kim, HS[Kim, Hyo Song]; Jung, M[Jung, Minkyu]; Lee, CK[Lee, Choong-kun]; Park, SR[Park, Sook Ryun]; Koo, DH[Koo, Dong-Hoe]; Lee, HW[Lee, Hyun Woo]; Bae, WK[Bae, Woo Kyun]; Jeung, HC[Jeung, Hei Cheul], et al.

ArticleIssue Date2021CitationCANCER RESEARCH, v.81, no.13PublisherAMER ASSOC CANCER RESEARCH

SCIESCOPUS

Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress

Oh, DY[Oh, Do-Youn]; Kim, JW[Kim, Jin Won]; Lee, MA[Lee, Myung Ah]; Kim, I[Kim, Ilhwan]; Lee, CK[Lee, Choong-kun]; Seol, YM[Seol, Young Mi]; Yoo, C[Yoo, Changhoon]; Oh, SC[Oh, Sang Cheul]; Bae, WK[Bae, Woo Kyun]; Chon, H[Chon, Hongjae], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.4PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Cheon, J[Cheon, Jaekyung]; Lee, CK[Lee, Choong-kun]; Sang, YB[Sang, Yun Beom]; Choi, HJ[Choi, Hye Jin]; Kim, MH[Kim, Min Hwan]; Ji, JH[Ji, Jun Ho]; Ko, KH[Ko, Kwang Hyun]; Kwon, CI[Kwon, Chang-Il]; Kim, DJ[Kim, Dae Jung]; Choi, SH[Choi, Sung Hoon], et al.

ArticleIssue Date2021CitationTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, v.13PublisherSAGE PUBLICATIONS LTD

SCIESCOPUS

YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells

Choi, SY[Choi, Sung Yong]; Bae, H[Bae, Hosung]; Jeong, SH[Jeong, Sun-Hye]; Park, I[Park, Intae]; Cho, H[Cho, Hyunsoo]; Hong, SP[Hong, Seon Pyo]; Lee, DH[Lee, Da-Hye]; Lee, CK[Lee, Choong-kun]; Park, JS[Park, Jin-Sung]; Suh, SH[Suh, Sang Heon], et al.

ArticleIssue Date2020CitationNATURE COMMUNICATIONS, v.11, no.1PublisherNATURE PUBLISHING GROUP

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Lee, CK[Lee, Choong-kun]Author

BROWSE